HIV Treatment Strategies
The Latest
Some Research on Pregnant and Postpartum Women with HIV Is Presented at CROI, But More Trials Are Needed
Pregnant people who are living with or vulnerable to HIV need to be included in clinical trials in order to close our knowledge gaps.
Contraceptives Don’t Increase HIV Risk, but They Do Interact With Some Antiretrovirals
A CROI 2020 roundup of studies on birth control and women living with HIV.
HIV Life Expectancy in U.S. Now Matches General Population—With Some Big “Buts”
The biggest may be that more of an HIV-positive person’s equally long lifespan will be spent managing comorbidities, one large study found.
This Week in HIV Research: Playing Catchup on the Aging Front
March 12, 2020: The impact of age on viral suppression and immunologic recovery; chronic obstructive pulmonary disease risk among older PLWHIV; sex-based differences in older men vs. women; effect of aging on drug-drug interactions.
Scientists Report Documented Sustained HIV Remission in a 4-Year-Old Child
Treating newborns with antiretroviral therapy in the hours after birth may help put HIV into remission.
The Monthly Injectable HIV Drug Works Just as Well When Given Every Two Months
Although injectable cabotegravir/rilpivirine is still yet to be approved by the FDA, evidence keeps mounting on the effectiveness of the shot for HIV treatment.
Durable HIV Remission in London Patient, the Second Person Cured of HIV
Researchers are happy but cautious, because this isn’t a strategy for most people with HIV.
Long-Acting Injectable HIV Meds Just as Good as Daily Pill for Newly Diagnosed and Those Already Undetectable
Questions still remain as to when FDA will approve, and how it will be implemented.
CROI 2020: What to Expect in HIV Science From This Year’s Conference
COVID-19 will impact both the program content and attendees this year, but there are still important HIV science presentations.
Retire? No, Thanks! This Doc Instead Moved to West Virginia to Fight HIV, Hepatitis C, and the Opioid Crisis
In a poor and conservative state, Judith Feinberg, M.D., aims to expand harm reduction—and bring treatment to active drug users.